MedPage Today asked policy experts and physicians whether a Trump administration would continue down that same path. "With respect to competition, it has actually been really heartening to see the ...
The court held that those patents did not satisfy the requirements for listing in the Orange Book, finding that the patents did not claim the drug or drug product for which the associated New Drug ...
The drug and device industries have a lot hinging on the results of the Nov. 5 U.S. presidential and congressional elections.
As America’s children prepare for their annual candy shakedown of America’s grown-ups, it’s time for regulators to get on the (broom)stick and fly in with an important public health ...
ANIP may be acquired soon with a potential offer exceeding $8 billion and contingent on FDA approval of a new drug filed in ...
Tremfya (guselkumab) is a prescription drug that’s used to treat certain autoimmune conditions, including plaque psoriasis. Tremfya can cause side effects that range from mild to serious.
Rexulti has boxed warnings. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). For details, see the “Side effect specifics” section. These are just a few ...
It is generally well appreciated that the pharmaceutical industry has entered a period of revenue underperformance. However, the severity of this underperformance, even when measured against ...
Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that ...
On Monday, October 7, 2024, the U.S. Supreme Court (“SCOTUS”) denied United Therapeutics Corporation (“UTC”) petition for certiorari clearing the way for Liquidia Corporation (“Liquidia ...
“There are genetic aspects, physical aspects, and inflammatory aspects,” he says. Ozempic can help people to lose weight, ...
In most cases, these side effects should be temporary. And some may be easily managed. But for symptoms that are ongoing or bothersome, talk with your doctor or pharmacist. And do not stop taking ...